David Moradi
CIK 1658843 · EXECUTIVE CHAIRMAN AND CPO · last filed 2026-10-02
David Moradi is an EXECUTIVE CHAIRMAN AND CPO who has filed 25 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider had shares withheld for taxes covering $38.3K of AEYE on Oct 2, 2026. Across all open-market trades the lifetime net is −$21.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $20.4M across reported positions. 12 SEC filings were submitted jointly with Sero Capital LLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AEYE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW YORK, NY 10021
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AEYE | EXECUTIVE CHAIRMAN AND CPO | 2,747,202 | $7.42 | $20.38M | -$22.69M | 21 | 2026-10-02 |
| HUMANIGEN, INC (KBIO) Delisted | Director | 778,210 | — | — | $1.68M | 2 | 2015-12-17 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-02 | AEYE | Tax (F) | −5,706 | -$38.3K | EDGAR |
| 2026-07-02 | AEYE | Tax (F) | −3,804 | -$22.1K | EDGAR |
| 2026-05-06 | AEYE | Mixed | −117,116 | -$121.6K | EDGAR |
| 2026-01-13 | AEYE | Tax (F) | −20,849 | -$197.6K | EDGAR |
| 2025-08-22 | AEYE | Mixed | −75,532 | -$296.4K | EDGAR |
| 2025-04-02 | AEYE | Grant (A) | +241,444 | $0 | EDGAR |
| 2025-01-22 | AEYE | Tax (F) | −35,725 | -$615.2K | EDGAR |
| 2024-12-20 | AEYE | Mixed | +37,242 | -$291.2K | EDGAR |
| 2024-12-06 | AEYE | Sell (S) | −900,000 | -$21.60M | EDGAR |
| 2024-11-14 | AEYE | Sell (S) | −134,043 | -$3.77M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.